Is CRISPR Therapeutics AG (CRSP) a Buy, Sell, or Hold?
NASDAQ : CRSP
CRISPR Therapeutics AG — Earnings Estimates
$52.1047 USD
-$0.35 (-0.66%)
- Volume
- 462.91K
- Average Volume
- 1.73M
- Market Capitalization
- $5.03B
- P/E Ratio
- -10.95
- Dividend Yield
- 0.00%
- Price Target
- $76.00
- Year High
- $78.48
- Year Low
- $44.12
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $17.85
Annual earnings financials
CRSP financial data with annual/quarterly toggle
Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.
CRSP Estimated and Actual Revenue by Quarter
CRSP Estimated and Actual EPS by Quarter
CRSP Analyst Forecasts — EBITDA & EBIT
| Quarter Date | No of Estimates | Ebitda | Ebit | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2027-12-30 | 5 | -81.84M | -1.12M | -19.26M | -83.9M | -1.15M | -19.74M |
| 2027-09-30 | 5 | -75.56M | -1.03M | -17.78M | -77.46M | -1.06M | -18.23M |
| 2027-06-30 | 5 | -66.52M | -907.98K | -15.65M | -68.19M | -930.78K | -16.05M |
| 2027-03-30 | 5 | -54.66M | -746.1K | -12.86M | -56.03M | -764.83K | -13.19M |
| 2026-12-30 | 5 | -45.61M | -622.62K | -10.73M | -46.76M | -638.25K | -11M |
| 2026-09-30 | 10 | -39.21M | -535.19K | -9.23M | -40.19M | -548.62K | -9.46M |
CRSP Analyst Forecasts — Net Income & SGA Expense
| Quarter Date | No of Estimates | NetIncome | SgaExpense | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2027-12-30 | 5 | -375.77M | 16.15M | -71.92M | 98.9M | 7.25B | 1.7B |
| 2027-09-30 | 5 | -381.75M | 16.41M | -73.07M | 91.3M | 6.69B | 1.57B |
| 2027-06-30 | 5 | -396.42M | 17.04M | -75.88M | 80.38M | 5.89B | 1.39B |
| 2027-03-30 | 5 | -435.38M | 18.72M | -83.33M | 66.05M | 4.84B | 1.14B |
| 2026-12-30 | 5 | -604.57M | 25.99M | -115.72M | 55.12M | 4.04B | 950.2M |
| 2026-09-30 | 10 | -127.11M | -94.61M | -113.73M | 47.38M | 3.47B | 816.77M |
CRSP Analyst Forecasts — Revenue & EPS
| Quarter Date | No of Revenue Estimates | Revenue | No of EPS Estimates | EPS | ||||
|---|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | |||
| 2027-12-30 | 5 | 1.91M | 140.22M | 32.99M | 4 | -3.89342 | 0.16737 | -0.74521 |
| 2027-09-30 | 5 | 1.77M | 129.45M | 30.46M | 8 | -3.95538 | 0.17003 | -0.75707 |
| 2027-06-30 | 5 | 1.56M | 113.97M | 26.82M | 5 | -4.10736 | 0.17656 | -0.78616 |
| 2027-03-30 | 5 | 1.28M | 93.65M | 22.04M | 4 | -4.51102 | 0.19392 | -0.86342 |
| 2026-12-30 | 5 | 1.07M | 78.15M | 18.39M | 4 | -6.26402 | 0.26927 | -1.19895 |
| 2026-09-30 | 10 | 916.91K | 67.17M | 15.81M | 11 | -1.31697 | -0.9803 | -1.17834 |